The latest research & treatment news about Hepatitis C infection, diagnosis, symptoms and treatment.

Menu Search

Frequency and Nature of the Variant Syndromes of Autoimmune Liver Disease

References

1. Johnson PJ, McFarlane IG, Alvarez F, Bianchi FB, Bianchi L, Burroughs A, Chapman RW, et al. Meeting report. International Autoimmune Hepatitis Group. HEPATOLOGY 1993; 18: 998-1005 [ Link previously at www.ncbi.nlm.nih.gov ].

2. Czaja AJ. Chronic active hepatitis: the challenge for a new nomenclature. Ann Intern Med 1993; 119: 510-517 [ Link previously at www.ncbi.nlm.nih.gov ].

3. Czaja AJ, Carpenter HA. Validation of a scoring system for the diagnosis of autoimmune hepatitis. Dig Dis Sci 1996; 41: 305-314 [ Link previously at www.ncbi.nlm.nih.gov ].

4. Czaja AJ. The variant forms of autoimmune hepatitis. Ann Intern Med 1996; 125: 588-598 [ Link previously at www.ncbi.nlm.nih.gov ].

5. Brunner G, Klinge O. A cholangitis with antinuclear antibodies (immunocholangitis) resembling chronic non-suppurative destructive cholangitis. Deutsche Med Wochenschr 1987; 112: 1454-1458 [ Link previously at www.ncbi.nlm.nih.gov ].

6. Ben-Ari Z, Dhillon AP, Sherlock S. Autoimmune cholangiopathy: part of the spectrum of autoimmune chronic active hepatitis. HEPATOLOGY 1993; 18: 10-15 [Abstract].

7. Michieletti P, Wanless IR, Katz A, Scheuer PJ, Yeaman SJ, Bassendine MF, Palmer JM, et al. Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut 1994; 35: 260-265[ Abstract].

8. Taylor SL, Dean PJ, Riely CA. Primary autoimmune cholangitis: an alternative to antimitochondrial antibody-negative primary biliary cirrhosis. Am J Clin Pathol 1994; 18: 91-99.

9. Goodman ZD, McNally PR, Davis DR, Ishak KG. Autoimmune cholangitis: a variant of primary biliary cirrhosis. Clinicopathologic and serologic correlations in 200 cases. Dig Dis Sci 1995; 40: 1232-1242 [ Link previously at www.ncbi.nlm.nih.gov ].

10. Kloppel G, Seifert G, Lindner H, Dammermann R, Sack HJ, Berg PA. Histopathological features in mixed types of chronic aggressive hepatitis and primary biliary cirrhosis. Correlations of liver histology with mitochondrial antibodies of different specificity. Virch Arch A Pathol Anat Histol 1977; 373: 143-160.

11. Minuk GY, Sutherland LR, Pappas SC, Kelly JK, Martin SE. Autoimmune chronic active hepatitis (lupoid hepatitis) and primary sclerosing cholangitis in two young adult females. Can J Gastroenterol 1988; 2: 22-27.

12. Rabinovitz M, Demetris AJ, Bou-Abboud CF, Van Thiel DH. Simultaneous occurrence of primary sclerosing cholangitis and autoimmune chronic active hepatitis in a patient with ulcerative colitis. Dig Dis Sci 1992; 37: 1606-1611 [ Link previously at www.ncbi.nlm.nih.gov ].

13. Wurbs D, Klein R, Terracciano L-M, Berg PA, Bianchi L. A 28-year-old woman with a combined hepatitic/cholestatic syndrome. HEPATOLOGY 1995; 22: 1598-1605[ [ Link previously at www.ncbi.nlm.nih.gov ].

14. Boberg KM, Fausa O, Haaland T, Holter E, Mellbye OJ, Spurkland A, Schrumpf E. Features of autoimmune hepatitis in primary sclerosing cholangitis: an evaluation of 114 primary sclerosing cholangitis patients according to a scoring system for the diagnosis of autoimmune hepatitis. HEPATOLOGY 1996; 23: 1369-1376[Abstract].

15. Gohlke F, Lohse AW, Dienes HP, Lohr H, Marker-Hermann E, Gerken G, Meyer zum Buschenfelde K-H. Evidence for an overlap syndrome of autoimmune hepatitis and primary sclerosing cholangitis. J Hepatol 1996; 24: 699-705 [ Link previously at www.ncbi.nlm.nih.gov ].

16. Luketic VA, Gomez DA, Sanyal AJ, Shiffman ML. An atypical presentation for primary sclerosing cholangitis. Dig Dis Sci 1997; 42: 2009-2016 [ Link previously at www.ncbi.nlm.nih.gov ].

17. Geubel AP, Baggenstoss AH, Summerskill WHJ. Responses to treatment can differentiate chronic active liver disease with cholangitic features from the primary biliary cirrhosis syndrome. Gastroenterology 1976; 71: 444-449 [Abstract].

18. Kenny RP, Czaja AJ, Ludwig J, Dickson ER. Frequency and significance of antimitochondrial antibodies in severe chronic active hepatitis. Dig Dis Sci 1986; 31: 705-711 [ Link previously at www.ncbi.nlm.nih.gov ].

19. Duclos-Vallee J-C, Hadengue A, Ganne-Carrie N, Robin E, Degott C, Erlinger S. Primary biliary cirrhosis-autoimmune hepatitis overlap syndrome: corticoresistance and effective treatment with cyclosporine A. Dig Dis Sci 1995; 40: 1069-1073 [ Link previously at www.ncbi.nlm.nih.gov ].

20. Lacerda MA, Ludwig J, Dickson ER, Jorgensen RA, Lindor KD. Antimitochondrial antibody-negative primary biliary cirrhosis. Am J Gastroenterol 1995; 90: 247-249[ [ Link previously at www.ncbi.nlm.nih.gov ].

21. Czaja AJ. Autoimmune hepatitis: evolving concepts and treatment strategies. Dig Dis Sci 1995; 40: 435-456 [ Link previously at www.ncbi.nlm.nih.gov ].

22. Czaja AJ, Manns MP. The validity and importance of subtypes in autoimmune hepatitis: a point of view. Am J Gastroenterol 1995; 90: 1206-1211 [ Link previously at www.ncbi.nlm.nih.gov ].

23. Wiesner RH, LaRusso NF, Ludwig J, Dickson ER. Comparison of the clinicopathologic features of primary sclerosing cholangitis and primary biliary cirrhosis. Gastroenterology 1985; 88: 108-114[Abstract].

24. Czaja AJ, Carpenter HA, Manns MP. Antibodies to soluble liver antigen, P450IID6, and mitochondrial complexes in chronic hepatitis. Gastroenterology 1993; 105: 1522-1528[Abstract].

25. Perdigoto R, Carpenter HA, Czaja AJ. Frequency and significance of chronic ulcerative colitis in severe corticosteroid-treated autoimmune hepatitis. J Hepatol 1992; 14: 325-331 [ Link previously at www.ncbi.nlm.nih.gov ].

26. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Genetic predispositions for the immunological features of chronic active hepatitis. HEPATOLOGY 1993; 18: 816-822[Abstract].

27. Czaja AJ, Nishioka M, Morshed SA, Hachiya T. Patterns of nuclear immunofluorescence and reactivities to recombinant nuclear antigens in autoimmune hepatitis. Gastroenterology 1994; 107: 200-207[Abstract].

28. Czaja AJ, Manns MP, Homburger HA. Frequency and significance of antibodies to liver/kidney microsome type 1 in adults with chronic active hepatitis. Gastroenterology 1992; 103: 1290-1295[Abstract].

29. Zein NN, Rakela J, Poterucha JJ, Steers JL, Wiesner RH, Persing DH. Hepatitis C genotypes in liver transplant recipients: Distribution and one year follow-up. Liver Transplant Surg 1995; 6: 354-357.

30. Czaja AJ, Carpenter HA. Sensitivity, specificity, and predictability of biopsy interpretations in chronic hepatitis. Gastroenterology 1993; 105: 1824-1832[Abstract].

31. Czaja AJ, Carpenter HA, Santrach PJ, Moore SB. Genetic predispositions for immunological features in chronic liver diseases other than autoimmune hepatitis. J Hepatol 1996; 24: 52-59.

32. Czaja AJ, Strettell MDJ, Thomson LJ, Santrach PJ, Moore SB, Donaldson PT, Williams R. Associations between alleles of the major histocompatibility complex and type 1 autoimmune hepatitis. HEPATOLOGY 1997; 25: 317-323[Abstract].

33. Summerskill WHJ, Korman MG, Ammon HV, Baggenstoss AH. Prednisone for chronic active liver disease: dose titration, standard dose, and combination with azathioprine compared. Gut 1975; 16: 876-883[Abstract].

34. Czaja AJ. Diagnosis, prognosis, and treatment of classical autoimmune chronic active hepatitis. In: Krawitt EL, Wiesner RH, eds. Autoimmune Liver Disease. New York: Raven, 1991:143-166.

Return To Article